FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Andrew Turrisi

Research Profile

Disorders

Concepts & Ideas

Procedures

Chemicals & Drugs

Activities & Behaviors

Drug Evaluation

Co-author Network

Publications

TOP 3
Fengming P Kong; James A Hayman; Kent Andrew Griffith; Gregory P Kalemkerian; Douglas Arenberg; Susan Lyons; Andrew Turrisi; Allen S Lichter; Benedick A Fraass; Avraham Eisbruch; Theodore S Lawrence; Randall TenHaken
Final toxicity results of a radiation-dose escalation study in patients with non-small-cell lung cancer (NSCLC): predictors for radiation pneumonitis and fibrosis.
Lawrence Marks; Jennifer Garst; Mark A Socinski; Gregory S Sibley; A. William Blackstock; James E Herndon; Sunmin Zhou; Timothy D Shafman; Andrea Tisch; Robert Clough; Xiaoli Yu; Andrew Turrisi; Mitchell S. Anscher; Jeffrey Crawford; Julian G Rosenman
Carboplatin/paclitaxel or carboplatin/vinorelbine followed by accelerated hyperfractionated conformal radiation therapy: report of a prospective phase I dose escalation trial from the Carolina Conformal Therapy Consortium.
Susan G Urba; Mark B Orringer; Andrew Turrisi; Mark D Iannettoni; Arlene A Forastiere; Myla S Strawderman
Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Andrew Turrisi (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2006: Fengming P Kong; James A Hayman; Kent Andrew Griffith; Gregory P Kalemkerian; Douglas Arenberg; Susan Lyons; Andrew Turrisi; Allen S Lichter; Benedick A Fraass; Avraham Eisbruch; Theodore S Lawrence; Randall TenHaken
Final toxicity results of a radiation-dose escalation study in patients with non-small-cell lung cancer (NSCLC): predictors for radiation pneumonitis and fibrosis.
International journal of radiation oncology, biology, physics 2006;65(4):1075-86.
2004: Lawrence Marks; Jennifer Garst; Mark A Socinski; Gregory S Sibley; A. William Blackstock; James E Herndon; Sunmin Zhou; Timothy D Shafman; Andrea Tisch; Robert Clough; Xiaoli Yu; Andrew Turrisi; Mitchell S. Anscher; Jeffrey Crawford; Julian G Rosenman
Carboplatin/paclitaxel or carboplatin/vinorelbine followed by accelerated hyperfractionated conformal radiation therapy: report of a prospective phase I dose escalation trial from the Carolina Conformal Therapy Consortium.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(21):4329-40.
2001: Susan G Urba; Mark B Orringer; Andrew Turrisi; Mark D Iannettoni; Arlene A Forastiere; Myla S Strawderman
Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(2):305-13.
2001: Mark A Socinski; Lawrence Marks; Jennifer Garst; Gregory S Sibley; A. William Blackstock; Andrew Turrisi; James Herndon; S Zhou; Mitchell S. Anscher; Jeffrey Crawford; Timothy D Shafman; Julian G Rosenman
Carboplatin/paclitaxel or carboplatin/vinorelbine followed by accelerated hyperfractionated conformal radiation therapy: a preliminary report of a phase I dose escalation trial from the Carolina Conformal Therapy Consortium.
The oncologist 2001;6 Suppl 1():20-4.
2001: James A Hayman; Mary K Martel; Randall TenHaken; Daniel Normolle; Robert F Todd III; JF Littles; Molly A Sullivan; PW Possert; Andrew Turrisi; Allen S Lichter
Dose escalation in non-small-cell lung cancer using three-dimensional conformal radiation therapy: update of a phase I trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(1):127-36.
1999: Mary K Martel; Randall TenHaken; MB Hazuka; Marc Kessler; Myla S Strawderman; Andrew Turrisi; Theodore S Lawrence; Benedick A Fraass; Allen S Lichter
Estimation of tumor control probability model parameters from 3-D dose distributions of non-small cell lung cancer patients.
Lung cancer (Amsterdam, Netherlands) 1999;24(1):31-7.
1998: Mary K Martel; WM Sahijdak; Randall TenHaken; Marc Kessler; Andrew Turrisi
Fraction size and dose parameters related to the incidence of pericardial effusions.
International journal of radiation oncology, biology, physics 1998;40(1):155-61.
1997: Mary K Martel; Myla S Strawderman; MB Hazuka; Andrew Turrisi; Benedick A Fraass; Allen S Lichter
Volume and dose parameters for survival of non-small cell lung cancer patients.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1997;44(1):23-9.
1997: John M Robertson; Randall TenHaken; MB Hazuka; Andrew Turrisi; Mary K Martel; AT Pu; JF Littles; Fernando J Martinez; Isaac R Francis; Leslie E Quint; Allen S Lichter
Dose escalation for non-small cell lung cancer using conformal radiation therapy.
International journal of radiation oncology, biology, physics 1997;37(5):1079-85.
1996: J D Naida; Avraham Eisbruch; S L Schoeppel; Howard M Sandler; Andrew Turrisi; Allen S Lichter
Analysis of localization errors in the definition of the mantle field using a beam's eye view treatment-planning system.
International journal of radiation oncology, biology, physics 1996;35(2):377-82.
1995: Andrew Turrisi
Combined platinum etoposide with radiation therapy in limited stage small cell lung cancer: an effective treatment strategy.
Lung cancer (Amsterdam, Netherlands) 1995;12 Suppl 3():S41-51.
1994: Andrew Turrisi
Platinum combined with radiation therapy in small cell lung cancer: focusing like a laser beam on crucial issues.
Seminars in oncology 1994;21(3 Suppl 6):36-42.
1994: W H Roa; MB Hazuka; Howard M Sandler; Mary K Martel; A F Thornton; Andrew Turrisi; Susan G Urba; Gregory T Wolf; Allen S Lichter
Results of primary and adjuvant CT-based 3-dimensional radiotherapy for malignant tumors of the paranasal sinuses.
International journal of radiation oncology, biology, physics 1994;28(4):857-65.
1994: Andrew Turrisi
Considerations on radiotherapy dose intensity for limited small cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 1994;10 Suppl 1():S167-73.
1994: Mary K Martel; Randall TenHaken; MB Hazuka; Andrew Turrisi; Benedick A Fraass; Allen S Lichter
Dose-volume histogram and 3-D treatment planning evaluation of patients with pneumonitis.
International journal of radiation oncology, biology, physics 1994;28(3):575-81.
1993: Randall TenHaken; Mary K Martel; Marc Kessler; MB Hazuka; Theodore S Lawrence; John M Robertson; Andrew Turrisi; Allen S Lichter
Use of Veff and iso-NTCP in the implementation of dose escalation protocols.
International journal of radiation oncology, biology, physics 1993;27(3):689-95.
1993: MB Hazuka; Andrew Turrisi; S T Lutz; Mary K Martel; Randall TenHaken; Myla S Strawderman; P L Borema; Allen S Lichter
Results of high-dose thoracic irradiation incorporating beam's eye view display in non-small cell lung cancer: a retrospective multivariate analysis.
International journal of radiation oncology, biology, physics 1993;27(2):273-84.
1993: MB Hazuka; Andrew Turrisi
The evolving role of radiation therapy in the treatment of locally advanced lung cancer.
Seminars in oncology 1993;20(2):173-84.
1993: Andrew Turrisi
Incorporation of radiotherapy fractionation in the combined-modality treatment of limited small-cell lung cancer.
Chest 1993;103(4 Suppl):418S-422S.
1993: Andrew Turrisi
Innovations in multimodality therapy for lung cancer. Combined modality management of limited small-cell lung cancer.
Chest 1993;103(1 Suppl):56S-59S.
1991: Andrew Turrisi
The integration of platinum and radiotherapy in the treatment of lung cancer.
Seminars in oncology 1991;18(1 Suppl 3):81-7.
1990: Andrew Turrisi; D J Glover
Thoracic radiotherapy variables: influence on local control in small cell lung cancer limited disease.
International journal of radiation oncology, biology, physics 1990;19(6):1473-9.
1990: Howard M Sandler; Walter Curran; Andrew Turrisi
The influence of tumor size and pre-treatment staging on outcome following radiation therapy alone for stage I non-small cell lung cancer.
International journal of radiation oncology, biology, physics 1990;19(1):9-13.
1988: W R Rate; Lawrence J Solin; Andrew Turrisi
Palliative radiotherapy for metastatic malignant melanoma: brain metastases, bone metastases, and spinal cord compression.
International journal of radiation oncology, biology, physics 1988;15(4):859-64.
1988: Andrew Turrisi; D J Glover; B A Mason
Response to Seydel.
International journal of radiation oncology, biology, physics 1988;15(3):797.
1988: Andrew Turrisi; D J Glover; B A Mason
A preliminary report: concurrent twice-daily radiotherapy plus platinum-etoposide chemotherapy for limited small cell lung cancer.
International journal of radiation oncology, biology, physics 1988;15(1):183-7.
1988: M M Kligerman; Andrew Turrisi; R C Urtasun; A L Norfleet; T L Phillips; T Barkley; Philip Rubin
Final report on phase I trial of WR-2721 before protracted fractionated radiation therapy.
International journal of radiation oncology, biology, physics 1988;14(6):1119-22.
1988: Andrew Turrisi; D J Glover; B A Mason
Concurrent twice-daily radiotherapy plus platinum-etoposide chemotherapy for the treatment of limited small cell lung cancer: a preliminary report.
Antibiotics and chemotherapy 1988;41():109-14.
1988: D Glover; K R Fox; C Weiler; M M Kligerman; Andrew Turrisi; John Glick
Clinical trials of WR-2721 prior to alkylating agent chemotherapy and radiotherapy.
Pharmacology & therapeutics 1988;39(1-3):3-7.
1988: L M Shaw; D Glover; Andrew Turrisi; D Q Brown; Heather S Bonner; A L Norfleet; C Weiler; John Glick; M M Kligerman
Pharmacokinetics of WR-2721.
Pharmacology & therapeutics 1988;39(1-3):195-201.
1986: Andrew Turrisi; D J Glover; S Hurwitz; J Glick; A L Norfleet; C Weiler; J M Yuhas; M M Kligerman
Final report of the phase I trial of single-dose WR-2721 [S-2-(3-aminopropylamino)ethylphosphorothioic acid].
Cancer treatment reports 1986;70(12):1389-93.
1986: D Glover; John Glick; C Weiler; K Fox; Andrew Turrisi; M M Kligerman
Phase I/II trials of WR-2721 and cis-platinum.
International journal of radiation oncology, biology, physics 1986;12(8):1509-12.
1986: L M Shaw; Andrew Turrisi; D J Glover; Heather S Bonner; A L Norfleet; C Weiler; M M Kligerman
Human pharmacokinetics of WR-2721.
International journal of radiation oncology, biology, physics 1986;12(8):1501-4.
1984: M M Kligerman; D J Glover; Andrew Turrisi; A L Norfleet; J M Yuhas; L R Coia; C Simone; John Glick; R L Goodman
Toxicity of WR-2721 administered in single and multiple doses.
International journal of radiation oncology, biology, physics 1984;10(9):1773-6.